| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0001780 | Neutrophil homeostasis | Affects phenotype | PMID:38648751 |
| GO:0004096 | Catalase activity | Decreases phenotype | PMID:20223270 |
| GO:0004784 | Superoxide dismutase activity | Increases phenotype | PMID:20223270 |
| GO:0006171 | Camp biosynthetic process | Increases phenotype | PMID:29790728 |
| GO:0007611 | Learning or memory | Decreases phenotype | PMID:17982161 |
| GO:0007626 | Locomotory behavior | Affects phenotype | PMID:21782714; PMID:21783602 |
| GO:0008283 | Cell population proliferation | Decreases phenotype | PMID:24451063 |
| GO:0008344 | Adult locomotory behavior | Decreases phenotype | PMID:17982161 |
| GO:0010001 | Glial cell differentiation | Increases phenotype | PMID:28851516 |
| GO:0010468 | Regulation of gene expression | Affects phenotype | PMID:38648751 |
| GO:0010890 | Positive regulation of sequestering of triglyceride | Increases phenotype | PMID:30903904 |
| GO:0010942 | Positive regulation of cell death | Increases phenotype | PMID:18550172; PMID:27015953; PMID:30202865 |
| GO:0016477 | Cell migration | Decreases phenotype | PMID:33969458 |
| GO:0019058 | Viral life cycle | Affects phenotype | PMID:23427858 |
| GO:0030182 | Neuron differentiation | Decreases phenotype | PMID:28851516 |
| GO:0031987 | Locomotion involved in locomotory behavior | Affects phenotype | PMID:26254212 |
| GO:0032125 | Micronucleus organization | Increases phenotype | PMID:39515574 |
| GO:0034599 | Cellular response to oxidative stress | Increases phenotype | PMID:20223270; PMID:20223270; PMID:24218147 |
| GO:0034614 | Cellular response to reactive oxygen species | Increases phenotype | PMID:24218147 |
| GO:0036269 | Swimming behavior | Decreases phenotype | PMID:17982161 |
| GO:0042403 | Thyroid hormone metabolic process | Affects phenotype | PMID:22759492 |
| GO:0042445 | Hormone metabolic process | Affects phenotype | PMID:23333513 |
| GO:0042632 | Cholesterol homeostasis | Affects phenotype | PMID:34425642 |
| GO:0043491 | Protein kinase b signaling | Increases phenotype | PMID:24218147 |
| GO:0044319 | Wound healing, spreading of cells | Increases phenotype | PMID:29790728 |
| GO:0045600 | Positive regulation of fat cell differentiation | Increases phenotype | PMID:30903904 |
| GO:0045851 | Ph reduction | Increases phenotype | PMID:31622892 |
| GO:0045931 | Positive regulation of mitotic cell cycle | Increases phenotype | PMID:30903904 |
| GO:0048709 | Oligodendrocyte differentiation | Decreases phenotype | PMID:33969458 |
| GO:0048874 | Host-mediated regulation of intestinal microbiota composition | Affects phenotype | PMID:38648751 |
| GO:0051348 | Negative regulation of transferase activity | Affects phenotype | PMID:29331935 |
| GO:0051923 | Sulfation | Decreases phenotype | PMID:29331935 |
| GO:0070346 | Positive regulation of fat cell proliferation | Increases phenotype | PMID:30903904 |
| GO:0070633 | Transepithelial transport | Increases phenotype | PMID:31622892 |
| GO:0071897 | Dna biosynthetic process | Increases phenotype | PMID:39668266 |
| GO:1901671 | Positive regulation of superoxide dismutase activity | Increases phenotype | PMID:20223270 |
| GO:1902255 | Positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator | Increases phenotype | PMID:15475174 |
| GO:1902552 | Negative regulation of catalase activity | Increases phenotype | PMID:20223270 |
| GO:1904358 | Positive regulation of telomere maintenance via telomere lengthening | Increases phenotype | PMID:34193151 |
| GO:2000448 | Positive regulation of macrophage migration inhibitory factor signaling pathway | Increases phenotype | PMID:38648751 |
| GO:2000609 | Regulation of thyroid hormone generation | Affects phenotype | PMID:25965908; PMID:39626304 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.